Edita Stokic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Edita Stokic has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Mia Manojlovic
University of Novi Sad, Faculty of Medicine in Novi Sad, Novi Sad, Serbia; Clinic for Endocrinology, Diabetes and Metabolic Disorders, University Clinical Center of Vojvodina, Novi Sad, Serbia
6 shared publications - Dragana Tomic Naglic
Faculty of Medicine, University of Novi Sad, 21137 Novi Sad, Serbia
4 shared publications - Esma R. Isenovic
VINČA Institute of Nuclear Sciences
3 shared publications - Ivana Bajkin
University of Novi Sad, Faculty of Medicine Novi Sad + University Clinical Center of Vojvodina, Clinic of Endocrinology, Diabetes and Metabolic Disorders, Novi Sad
3 shared publications - Tijana Icin
University of Novi Sad, Faculty of Medicine, Novi Sad + University Clinical Center of Vojvodina, Novi Sad
3 shared publications - Aljosa Mandic
Oncology Institute of Vojvodina, Serbia; University of Novi Sad, Medical Faculty, Serbia
2 shared publications
Latest Publications
- Open Access
- 23 October 2025
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 26 (4) , 547-558
Mitochondrial dysfunction, reactive oxygen species, and diabetes mellitus – A triangular relationship: A review
Diabetes mellitus (DM) disrupts cellular homeostasis and is characterized by mitochondrial structural and functional impairments similar to those found in other metabolic disorders. Mitochondrial dysfunction (MD) leads to the excessive production of reactive oxygen species (ROS), which are central to the progression of cardiovascular (CV) disease—the leading cause of mortality associated with DM. ROS-driven oxidative stress (OS) is implicated in cardiac injury in both clinical and experimental contexts. This review synthesizes recent literature on the role of MD in the development and progression of DM and its associated CV complications, highlighting disrupted pathways that regulate the balance between ROS production and antioxidant defenses. We summarize alterations in mitochondrial dynamics—including fusion, fission, and mitophagy—mtDNA damage, and impaired oxidative phosphorylation characterized by dysregulated mitochondrial membrane potential (ΔΨm), electron transport chain (ETC) defects, uncoupling, and substrate overload. Additionally, we discuss hyperglycemia-activated pathways such as polyol flux, AGE–RAGE interactions, protein kinase C/nicotinamide adenine dinucleotide phosphate (PKC/NADPH) oxidase activation, and poly(ADP-ribose) polymerase 1 (PARP-1)-mediated glyceraldehyde-3-phosphate dehydrogenase (GAPDH) inhibition, which contribute to inflammation, endothelial dysfunction, β-cell failure, insulin resistance, and micro/macrovascular injury. Diagnostic and biomarker strategies encompass mtDNA analysis, bioenergetic assays, metabolomics, proteomics, and imaging techniques including PET, MRI, and NIRS. Therapeutic approaches aimed at restoring mitochondrial function and mitigating OS include mitochondria-targeted antioxidants (such as MitoQ, CoQ10, SkQ1, SS-31, and Mito-TEMPO), metabolic drugs (including metformin and SGLT2 inhibitors), lifestyle modifications, and emerging gene-editing technologies. The interplay between mitochondria, ROS, and DM reflects a tightly regulated aspect of cellular physiology; while targeted and personalized strategies hold promise, they necessitate rigorous evaluation.
- 23 October 2025
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 26 (4) , 547-558
Open AccessMitochondrial dysfunction, reactive oxygen species, and diabetes mellitus – A triangular relationship: A review
Diabetes mellitus (DM) disrupts cellular homeostasis and is characterized by mitochondrial structural and functional impairments similar to those found in other metabolic disorders. Mitochondrial dysfunction (MD) leads to the excessive production of reactive oxygen species (ROS), which are central to the progression of cardiovascular (CV) disease—the leading cause of mortality associated with DM. ROS-driven oxidative stress (OS) is implicated in cardiac injury in both clinical and experimental contexts. This review synthesizes recent literature on the role of MD in the development and progression of DM and its associated CV complications, highlighting disrupted pathways that regulate the balance between ROS production and antioxidant defenses. We summarize alterations in mitochondrial dynamics—including fusion, fission, and mitophagy—mtDNA damage, and impaired oxidative phosphorylation characterized by dysregulated mitochondrial membrane potential (ΔΨm), electron transport chain (ETC) defects, uncoupling, and substrate overload. Additionally, we discuss hyperglycemia-activated pathways such as polyol flux, AGE–RAGE interactions, protein kinase C/nicotinamide adenine dinucleotide phosphate (PKC/NADPH) oxidase activation, and poly(ADP-ribose) polymerase 1 (PARP-1)-mediated glyceraldehyde-3-phosphate dehydrogenase (GAPDH) inhibition, which contribute to inflammation, endothelial dysfunction, β-cell failure, insulin resistance, and micro/macrovascular injury. Diagnostic and biomarker strategies encompass mtDNA analysis, bioenergetic assays, metabolomics, proteomics, and imaging techniques including PET, MRI, and NIRS. Therapeutic approaches aimed at restoring mitochondrial function and mitigating OS include mitochondria-targeted antioxidants (such as MitoQ, CoQ10, SkQ1, SS-31, and Mito-TEMPO), metabolic drugs (including metformin and SGLT2 inhibitors), lifestyle modifications, and emerging gene-editing technologies. The interplay between mitochondria, ROS, and DM reflects a tightly regulated aspect of cellular physiology; while targeted and personalized strategies hold promise, they necessitate rigorous evaluation.
- 12 December 2024
- Published by Springer Nature
- p. 177-188
Adipose Tissue Angiogenesis and Clinical Implications
- 12 December 2024
- Published by Springer Nature
- p. 177-188
Adipose Tissue Angiogenesis and Clinical Implications
- Open Access
- 15 November 2024
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 25 (4) , 751-760
Hormone replacement therapy in surgical menopause after gynecological malignancies
This review examines hormone replacement therapy (HRT) in cases of surgical menopause following gynecological malignancies. It aims to capture current knowledge, summarize recent findings, and provide recommendations for clinical settings. Unlike natural menopause, surgical menopause occurs abruptly, without an adjustment period, and is associated with a notably higher risk of fractures, arthritis, cognitive decline, dementia, Parkinson’s disease, and various metabolic disorders affecting glucose and lipid levels—all of which contribute to an increased risk of major cardiovascular events. In 2017, The North American Menopause Society recommended that, barring contraindications, HRT should be initiated in women who enter surgical menopause before age 45. If these women do not experience vasomotor symptoms or other issues, HRT should be maintained consistently at least until age 52. This guideline reflects contemporary knowledge and is the result of a multidisciplinary consensus, based on a review of existing literature and several randomized clinical trials focusing on women who have survived gynecological cancers and whose quality of life is significantly impacted by surgical or early menopause. Estrogen supplementation is particularly beneficial, as it is linked to marked improvements in quality of life, including delayed onset of chronic cardiovascular issues, reduced fracture risk, enhanced cognitive function, reduced inflammation, and improved self-esteem, as well as better social and work performance. Clinical implementation of HRT, however, requires a highly individualized approach. This approach must consider the type and stage of malignancy, histopathological characteristics, risk factors for recurrence (such as diet, concurrent medications, medical history, and genetic predispositions), and a thorough assessment of the potential benefits and risks of HRT, as well as the patient’s personal wishes and expectations.
- 15 November 2024
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 25 (4) , 751-760
Open AccessHormone replacement therapy in surgical menopause after gynecological malignancies
This review examines hormone replacement therapy (HRT) in cases of surgical menopause following gynecological malignancies. It aims to capture current knowledge, summarize recent findings, and provide recommendations for clinical settings. Unlike natural menopause, surgical menopause occurs abruptly, without an adjustment period, and is associated with a notably higher risk of fractures, arthritis, cognitive decline, dementia, Parkinson’s disease, and various metabolic disorders affecting glucose and lipid levels—all of which contribute to an increased risk of major cardiovascular events. In 2017, The North American Menopause Society recommended that, barring contraindications, HRT should be initiated in women who enter surgical menopause before age 45. If these women do not experience vasomotor symptoms or other issues, HRT should be maintained consistently at least until age 52. This guideline reflects contemporary knowledge and is the result of a multidisciplinary consensus, based on a review of existing literature and several randomized clinical trials focusing on women who have survived gynecological cancers and whose quality of life is significantly impacted by surgical or early menopause. Estrogen supplementation is particularly beneficial, as it is linked to marked improvements in quality of life, including delayed onset of chronic cardiovascular issues, reduced fracture risk, enhanced cognitive function, reduced inflammation, and improved self-esteem, as well as better social and work performance. Clinical implementation of HRT, however, requires a highly individualized approach. This approach must consider the type and stage of malignancy, histopathological characteristics, risk factors for recurrence (such as diet, concurrent medications, medical history, and genetic predispositions), and a thorough assessment of the potential benefits and risks of HRT, as well as the patient’s personal wishes and expectations.
- Open Access
- 2 October 2024
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 25 (3) , 693-700
Correlation between blood cell indices and adiponectin and leptin levels in COVID-19
Adipose tissue (AT) is a major metabolic organ, functioning through autocrine, paracrine, and endocrine mechanisms. This study investigated the relationship between adipokine levels and blood cell indices, particularly platelets, in individuals with COVID-19. Another aim was to enhance the understanding of AT's endocrine function during dynamic pathological changes, such as acute viral infections like COVID-19. The study was conducted as a cross-sectional analysis at the University Clinical Center of Vojvodina in 2021 and 2022, including 76 consecutive SARS-CoV-2-positive patients of both sexes. Study parameters were determined from peripheral venous blood samples routinely collected upon hospital admission. The results showed that leptin levels were significantly positively correlated with body mass index (BMI) (ρ = 0.421, P < 0.001) and body fat mass (BFM) (ρ = 0.547, P < 0.001). Simultaneously, a significant negative correlation was observed between adiponectin levels and BMI (ρ = −0.430, P < 0.001). Additionally, a significant positive correlation was found between leptin levels and mean platelet volume (MPV) (ρ = 0.307, P < 0.05), platelet distribution width (PDW) (ρ = 0.325, P < 0.05), and platelet-large cell ratio (P-LCR) (ρ = 0.305, P < 0.05). Leptin's impact on platelet indices was confirmed in both simple and multiple linear regression models, where leptin exhibited a slightly higher beta coefficient than BMI. In contrast, adiponectin levels were negatively correlated with hematocrit (HCT) (ρ = −0.329, P < 0.05). These findings may provide further insight into the previously suspected role of AT in the complex cascade of COVID-19 pathogenesis and platelet activation.
- 2 October 2024
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 25 (3) , 693-700
Open AccessCorrelation between blood cell indices and adiponectin and leptin levels in COVID-19
Adipose tissue (AT) is a major metabolic organ, functioning through autocrine, paracrine, and endocrine mechanisms. This study investigated the relationship between adipokine levels and blood cell indices, particularly platelets, in individuals with COVID-19. Another aim was to enhance the understanding of AT's endocrine function during dynamic pathological changes, such as acute viral infections like COVID-19. The study was conducted as a cross-sectional analysis at the University Clinical Center of Vojvodina in 2021 and 2022, including 76 consecutive SARS-CoV-2-positive patients of both sexes. Study parameters were determined from peripheral venous blood samples routinely collected upon hospital admission. The results showed that leptin levels were significantly positively correlated with body mass index (BMI) (ρ = 0.421, P < 0.001) and body fat mass (BFM) (ρ = 0.547, P < 0.001). Simultaneously, a significant negative correlation was observed between adiponectin levels and BMI (ρ = −0.430, P < 0.001). Additionally, a significant positive correlation was found between leptin levels and mean platelet volume (MPV) (ρ = 0.307, P < 0.05), platelet distribution width (PDW) (ρ = 0.325, P < 0.05), and platelet-large cell ratio (P-LCR) (ρ = 0.305, P < 0.05). Leptin's impact on platelet indices was confirmed in both simple and multiple linear regression models, where leptin exhibited a slightly higher beta coefficient than BMI. In contrast, adiponectin levels were negatively correlated with hematocrit (HCT) (ρ = −0.329, P < 0.05). These findings may provide further insight into the previously suspected role of AT in the complex cascade of COVID-19 pathogenesis and platelet activation.
- Open Access
- 19 May 2024
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 24 (4) , 787-797
Metabolic dysregulation in obese women and the carcinogenesis of gynecological tumors: A review
Obesity is a significant health issue associated with increased cancer risks, including gynecological malignancies. The worldwide rise in obesity rates is significantly impacting both cancer development and treatment outcomes. Adipose tissue plays a crucial role in metabolism, secreting various substances that can influence cancer formation. In obese individuals, dysfunctional adipose tissue can contribute to cancer development through inflammation, insulin resistance, hormonal changes, and abnormal cholesterol metabolism. Studies have shown a strong correlation between obesity and gynecological cancers, particularly endometrial and breast cancers. Obesity not only increases the risk of developing these cancers but is also associated with poorer outcomes. Additionally, obesity affects the perioperative management of gynecological cancers, requiring specialized care due to increased complications and resistance to therapy. Treatment strategies for managing metabolic dysregulation in patients with gynecological cancers include weight management, statin therapy, and insulin-sensitizing medications. Emerging studies suggest that interventions like intermittent fasting and caloric restriction may enhance the effectiveness of cancer treatments. Furthermore, targeting cholesterol metabolism, such as with statins or proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, shows potential in cancer therapy. In conclusion, addressing metabolic issues, particularly obesity, is crucial in preventing and treating gynecological malignancies. Personalized approaches focusing on weight management and metabolic reprogramming may improve outcomes in these patients.
- 19 May 2024
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 24 (4) , 787-797
Open AccessMetabolic dysregulation in obese women and the carcinogenesis of gynecological tumors: A review
Obesity is a significant health issue associated with increased cancer risks, including gynecological malignancies. The worldwide rise in obesity rates is significantly impacting both cancer development and treatment outcomes. Adipose tissue plays a crucial role in metabolism, secreting various substances that can influence cancer formation. In obese individuals, dysfunctional adipose tissue can contribute to cancer development through inflammation, insulin resistance, hormonal changes, and abnormal cholesterol metabolism. Studies have shown a strong correlation between obesity and gynecological cancers, particularly endometrial and breast cancers. Obesity not only increases the risk of developing these cancers but is also associated with poorer outcomes. Additionally, obesity affects the perioperative management of gynecological cancers, requiring specialized care due to increased complications and resistance to therapy. Treatment strategies for managing metabolic dysregulation in patients with gynecological cancers include weight management, statin therapy, and insulin-sensitizing medications. Emerging studies suggest that interventions like intermittent fasting and caloric restriction may enhance the effectiveness of cancer treatments. Furthermore, targeting cholesterol metabolism, such as with statins or proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, shows potential in cancer therapy. In conclusion, addressing metabolic issues, particularly obesity, is crucial in preventing and treating gynecological malignancies. Personalized approaches focusing on weight management and metabolic reprogramming may improve outcomes in these patients.
- Open Access
The Effect of Recruitment Maneuver on Static Lung Compliance in Patients Undergoing General Anesthesia for Laparoscopic Cholecystectomy: A Single-Centre Prospective Clinical Intervention Study
Background and Objectives: The aim of this study was to examine whether the use of an alveolar recruitment maneuver (RM) leads to a significant increase in static lung compliance (Cstat) and an improvement in gas exchange in patients undergoing laparoscopic cholecystectomy. Material and Methods: A clinical prospective intervention study was conducted. Patients were divided into two groups according to their body mass index (BMI): normal-weight (group I) and pre-obese and obese grade I (group II). Lung mechanics were monitored (Cstat, dynamic compliance—Cdin, peak pressure—Ppeak, plateau pressure—Pplat, driving pressure—DP) alongside gas exchange, and hemodynamic changes (heart rate—HR, mean arterial pressure—MAP) at six time points: T1 (induction of anesthesia), T2 (formation of pneumoperitoneum), T3 (RM with a PEEP of 5 cm H2O), T4 (RM with a PEEP of 7 cm H2O), T5 (desufflation), and T6 (RM at the end). The RM was performed by increasing the peak pressure by +5 cm of H2O at an equal inspiration-to-expiration ratio (I/E = 1:1) and applying a PEEP of 5 and 7 cm of H2O. Results: Out of 96 patients, 33 belonged to group I and 63 to group II. An increase in Cstat values occurred after all three RMs. At each time point, the Cstat value was measured higher in group I than in group II. A higher increase in Cstat was observed in group II after the second and third RM. Cstat values were higher at the end of the surgical procedure compared to values after the induction of anesthesia. The RM led to a significant increase in PaO2 in both groups without changes in HR or MAP. Conclusions: During laparoscopic cholecystectomy, the application of RM leads to a significant increase in Cstat and an improvement in gas exchange. The prevention of atelectasis during anesthesia should be initiated immediately after the induction of anesthesia, using protective mechanical ventilation and RM.
Open AccessThe Effect of Recruitment Maneuver on Static Lung Compliance in Patients Undergoing General Anesthesia for Laparoscopic Cholecystectomy: A Single-Centre Prospective Clinical Intervention Study
Background and Objectives: The aim of this study was to examine whether the use of an alveolar recruitment maneuver (RM) leads to a significant increase in static lung compliance (Cstat) and an improvement in gas exchange in patients undergoing laparoscopic cholecystectomy. Material and Methods: A clinical prospective intervention study was conducted. Patients were divided into two groups according to their body mass index (BMI): normal-weight (group I) and pre-obese and obese grade I (group II). Lung mechanics were monitored (Cstat, dynamic compliance—Cdin, peak pressure—Ppeak, plateau pressure—Pplat, driving pressure—DP) alongside gas exchange, and hemodynamic changes (heart rate—HR, mean arterial pressure—MAP) at six time points: T1 (induction of anesthesia), T2 (formation of pneumoperitoneum), T3 (RM with a PEEP of 5 cm H2O), T4 (RM with a PEEP of 7 cm H2O), T5 (desufflation), and T6 (RM at the end). The RM was performed by increasing the peak pressure by +5 cm of H2O at an equal inspiration-to-expiration ratio (I/E = 1:1) and applying a PEEP of 5 and 7 cm of H2O. Results: Out of 96 patients, 33 belonged to group I and 63 to group II. An increase in Cstat values occurred after all three RMs. At each time point, the Cstat value was measured higher in group I than in group II. A higher increase in Cstat was observed in group II after the second and third RM. Cstat values were higher at the end of the surgical procedure compared to values after the induction of anesthesia. The RM led to a significant increase in PaO2 in both groups without changes in HR or MAP. Conclusions: During laparoscopic cholecystectomy, the application of RM leads to a significant increase in Cstat and an improvement in gas exchange. The prevention of atelectasis during anesthesia should be initiated immediately after the induction of anesthesia, using protective mechanical ventilation and RM.
- Open Access
- 1 January 2023
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 151 (3-4) , 259-263
Dr Aleksandar Sosberger - the first director of the Novi Sad City Hospital
The first director of the City Hospital in Novi Sad, which eventually grew into the modern Clinical Center of Vojvodina, was Dr Aleksandar-Šandor Šosberger, who was born in Novi Sad on September 13, 1873. He graduated on the Faculty of Medicine in Budapest, and then trained in hospitals in numerous European cities. The desire for learning and further training led him to specialize in the field of gynecology and obstetrics, and he became the first specialist gynecologist-obstetrician in Vojvodina. At the beginning of the 20th century, with the sudden increase in the number of inhabitants of Novi Sad, the existing hospitals were not sufficient for the hospitalization of the patients, thus the City Magistrate made a decision to build a new City Hospital in April 1907, the construction of which was completed in 1909, and then built facilities are units in which some clinics of the Clinical Center of Vojvodina are still located nowadays. It was organized in such a way that it had Internal Medicine, Surgical, Dermatology-Venereology and Gynecology-Obstetrics departments, with a bed capacity of about 300 beds. Recognizing his comprehensive education, experience, high expertise, intelligence and organizational skills, Dr Aleksandar Šosberger was appointed as the first manager of the newly built City Hospital. He was the first in the City Hospital to apply the Wasserman reaction, and he installed the first X-ray machine in Novi Sad, for his private practice. As the first gynecologist-obstetrician specialist in Vojvodina, he made a great contribution to the introduction and improvement of surgical techniques. Dr Aleksandar Šosberger showed that with dedicated professional work and responsibility, great results and improvements in the field of healthcare can be achieved, as evidenced by the fact that the City Hospital, over time, grew into a tertiary healthcare institution, the Clinical Center of Vojvodina.
- 1 January 2023
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 151 (3-4) , 259-263
Open AccessDr Aleksandar Sosberger - the first director of the Novi Sad City Hospital
The first director of the City Hospital in Novi Sad, which eventually grew into the modern Clinical Center of Vojvodina, was Dr Aleksandar-Šandor Šosberger, who was born in Novi Sad on September 13, 1873. He graduated on the Faculty of Medicine in Budapest, and then trained in hospitals in numerous European cities. The desire for learning and further training led him to specialize in the field of gynecology and obstetrics, and he became the first specialist gynecologist-obstetrician in Vojvodina. At the beginning of the 20th century, with the sudden increase in the number of inhabitants of Novi Sad, the existing hospitals were not sufficient for the hospitalization of the patients, thus the City Magistrate made a decision to build a new City Hospital in April 1907, the construction of which was completed in 1909, and then built facilities are units in which some clinics of the Clinical Center of Vojvodina are still located nowadays. It was organized in such a way that it had Internal Medicine, Surgical, Dermatology-Venereology and Gynecology-Obstetrics departments, with a bed capacity of about 300 beds. Recognizing his comprehensive education, experience, high expertise, intelligence and organizational skills, Dr Aleksandar Šosberger was appointed as the first manager of the newly built City Hospital. He was the first in the City Hospital to apply the Wasserman reaction, and he installed the first X-ray machine in Novi Sad, for his private practice. As the first gynecologist-obstetrician specialist in Vojvodina, he made a great contribution to the introduction and improvement of surgical techniques. Dr Aleksandar Šosberger showed that with dedicated professional work and responsibility, great results and improvements in the field of healthcare can be achieved, as evidenced by the fact that the City Hospital, over time, grew into a tertiary healthcare institution, the Clinical Center of Vojvodina.
- Open Access
- 17 August 2022
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 9, 969996
Potential health benefits of blueberry and raspberry pomace as functional food ingredients: Dietetic intervention study on healthy women volunteers
The fruit juice industry generates pomace as a valuable by-product especially rich in polyphenols, dietary fibers, vitamins, minerals, and unsaturated fatty acids. In the cookies used in this study, 30% of the gluten-free flour was replaced with dried and ground blueberry and raspberry pomace, rich source of polyphenols, dietary fibers, linoleic and alpha-linolenic acid. In order to examine whether the addition of blueberry and raspberry pomace in cookie formulation can have beneficial effects on certain blood parameters and anthropometric measurements, the designed cookies were tested in 20 healthy, normally fed female subjects, aged 30–50 years (41.35 ± 8.58 years) over four-week dietetic intervention study. Significant changes in the composition of fatty acids serum phospholipids, decrease in LDL-cholesterol level (20.16%), increase in adiponectin level (25.52%) and decrease in ALT and AST values were observed, thus indicating that inclusion of cookies containing blueberry and raspberry dried and ground pomace to usual diet might have positive effects on certain cardiovascular risk factors and liver function indicators.
- 17 August 2022
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 9, 969996
Open AccessPotential health benefits of blueberry and raspberry pomace as functional food ingredients: Dietetic intervention study on healthy women volunteers
The fruit juice industry generates pomace as a valuable by-product especially rich in polyphenols, dietary fibers, vitamins, minerals, and unsaturated fatty acids. In the cookies used in this study, 30% of the gluten-free flour was replaced with dried and ground blueberry and raspberry pomace, rich source of polyphenols, dietary fibers, linoleic and alpha-linolenic acid. In order to examine whether the addition of blueberry and raspberry pomace in cookie formulation can have beneficial effects on certain blood parameters and anthropometric measurements, the designed cookies were tested in 20 healthy, normally fed female subjects, aged 30–50 years (41.35 ± 8.58 years) over four-week dietetic intervention study. Significant changes in the composition of fatty acids serum phospholipids, decrease in LDL-cholesterol level (20.16%), increase in adiponectin level (25.52%) and decrease in ALT and AST values were observed, thus indicating that inclusion of cookies containing blueberry and raspberry dried and ground pomace to usual diet might have positive effects on certain cardiovascular risk factors and liver function indicators.
- 1 January 2021
- Published by National Library of Serbia in Medicinski Pregled
- Vol. 74 (1-2) , 15-19
Nutritional status of pregnant women - effects on the course and pregnancy outcome
Introduction. In recent decades, obesity has taken on epidemic proportions and is becoming one of the most significant public health problems today. The results of clinical and epidemiological studies show that obese pregnant women can be considered a high risk group, given the increased risk of maternal and fetal complications. The aim of this study was to examine the relationship between pregnant women?s nutritional status and the development of arterial hypertension, gestational diabetes and obstetric cholestasis during pregnancy, as well as the impact of pregnant women?s nutritional status on newborn birth weight and vital parameters at birth, assessed by Apgar score. Material and Methods. This retrospective study included 71 pregnant women who were divided into two groups, depending on the nutritional status. The first group included 28 pregnant women with a body mass index < 25 kg/m? or less, whereas the second group included obese pregnant women with a body mass index > 30 kg/m? or more. Birth protocol data were used for the newborns. Results. In obese pregnant women, the termination of pregnancy by cesarean section was statistically significant more frequent (p < 0.05). Newborns of obese mothers had a statistically lower Apgar score at 5 minutes, while higher body weight of newborns and a lower Apgar score at 1 minute were at the limit of statistical significance (p = 0.068). Arterial hypertension was more common in obese pregnant women (p = 0.014), while gestational diabetes (p = 0.42) and obstetric cholestasis (p = 0.51) were more common in obese pregnant women, but without statistical significance. Conclusion. Obesity in pregnancy is a risk factor for the development of hypertension, a higher incidence of cesarean section, and a lower Apgar score of newborns.
- 1 January 2021
- Published by National Library of Serbia in Medicinski Pregled
- Vol. 74 (1-2) , 15-19
Nutritional status of pregnant women - effects on the course and pregnancy outcome
Introduction. In recent decades, obesity has taken on epidemic proportions and is becoming one of the most significant public health problems today. The results of clinical and epidemiological studies show that obese pregnant women can be considered a high risk group, given the increased risk of maternal and fetal complications. The aim of this study was to examine the relationship between pregnant women?s nutritional status and the development of arterial hypertension, gestational diabetes and obstetric cholestasis during pregnancy, as well as the impact of pregnant women?s nutritional status on newborn birth weight and vital parameters at birth, assessed by Apgar score. Material and Methods. This retrospective study included 71 pregnant women who were divided into two groups, depending on the nutritional status. The first group included 28 pregnant women with a body mass index < 25 kg/m? or less, whereas the second group included obese pregnant women with a body mass index > 30 kg/m? or more. Birth protocol data were used for the newborns. Results. In obese pregnant women, the termination of pregnancy by cesarean section was statistically significant more frequent (p < 0.05). Newborns of obese mothers had a statistically lower Apgar score at 5 minutes, while higher body weight of newborns and a lower Apgar score at 1 minute were at the limit of statistical significance (p = 0.068). Arterial hypertension was more common in obese pregnant women (p = 0.014), while gestational diabetes (p = 0.42) and obstetric cholestasis (p = 0.51) were more common in obese pregnant women, but without statistical significance. Conclusion. Obesity in pregnancy is a risk factor for the development of hypertension, a higher incidence of cesarean section, and a lower Apgar score of newborns.
- Open Access
- 1 January 2019
- Published by United Scientific Group in Journal of Obesity and Chronic Diseases
- Vol. 03 (02)
Proceedings of the Fifth International Conference on Obesity and Chronic Diseases (ICOCD-2019)
Low carbohydrate diets are a matter of controversy for more than hundred years. From time to time this kind of diets are highly popular.
- 1 January 2019
- Published by United Scientific Group in Journal of Obesity and Chronic Diseases
- Vol. 03 (02)
Open AccessProceedings of the Fifth International Conference on Obesity and Chronic Diseases (ICOCD-2019)
Low carbohydrate diets are a matter of controversy for more than hundred years. From time to time this kind of diets are highly popular.